KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Cash from Investing Activities: 2009-2025

Historic Cash from Investing Activities for Clorox (CLX) over the last 15 years, with Sep 2025 value amounting to -$34.0 million.

  • Clorox's Cash from Investing Activities fell 138.20% to -$34.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$217.0 million, marking a year-over-year decrease of 244.44%. This contributed to the annual value of -$94.0 million for FY2025, which is 46.29% up from last year.
  • According to the latest figures from Q3 2025, Clorox's Cash from Investing Activities is -$34.0 million, which was up 55.26% from -$76.0 million recorded in Q2 2025.
  • In the past 5 years, Clorox's Cash from Investing Activities ranged from a high of $89.0 million in Q3 2024 and a low of -$111.0 million during Q2 2021.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$53.0 million (2025), whereas its average is -$39.9 million.
  • In the last 5 years, Clorox's Cash from Investing Activities surged by 486.96% in 2024 and then plummeted by 138.20% in 2025.
  • Clorox's Cash from Investing Activities (Quarterly) stood at -$56.0 million in 2021, then rose by 25.00% to -$42.0 million in 2022, then climbed by 21.43% to -$33.0 million in 2023, then plummeted by 63.64% to -$54.0 million in 2024, then crashed by 138.20% to -$34.0 million in 2025.
  • Its last three reported values are -$34.0 million in Q3 2025, -$76.0 million for Q2 2025, and -$53.0 million during Q1 2025.